References
- Katz A. M. Effects of digitalis on cell biochemistry : Sodium pump inhibition. J. Am. Coll. Cardiol. 1985; 5(5)16A–21A
- Haddy F. J., Pamnani M. B., Clough D. L. Frontiers in hypertension research, J. H. Laragh, F. R. Buhler, D. W. Seldin. Springer Verlag, New York 1981; 71–83
- Kuske R., Moreth K., Renner D., Wizemann V., Schoner W. Sodium pump inhibitor in the serum of patients with essential hypertension and its partial purification from hemofiltrate. Klin. Wochenschr. 1987; 65: 53–59
- Haupert G. T., Sancho J. M. Sodium transport inhibitor from bovine hypothalamus. Proc. Natl. Acad. Sci. 1979; 76: 4658–4660
- Illescas M., Ricote M., Méndez E., Sancho J. M. Ouabain-like (Na/K)ATPase inhibitor isolated from bovine hypotalamus. Life Sci. Adv. 1987; 6: 1–5
- Carilli C. T., Berne M., Cantley L. C., Haupert G. T. Hypothalamic factor inhibits the (Na/K)ATPase from the extracellular surface. J. Biol. Chem. 1985; 260(2)1027–1031
- Jorgensen P. L. Purification and characterization of (Na,K)-ATPase. Biochim. Biophys. Acta 1974; 356: 36–52
- Cantley L. C., Jr., Cantley Ll. G., Josephson L. A characterization of vanadate interactions with the (Na,K)-ATPase. Mechanistic and regulatory implications. J. Biol. Chem. 1978; 253: 7361–7368
- Morgan K., Lewis M. D., Spurlock G., Collins P. A., Foord S. M., Southgate K., Scanlon M. F., Mir M. A. Characterization and partial purification of the sodium-potassium-ATPase inhibitor released from cultured rat hypothalamic cells. J. Bio. Chem. 1985; 260: 13595–13600
- MacGregor G. A., De Wardener H. E. A circulating sodium transport inhibitor and essential hypertension. J. Cardiov. Pharmacol. 1984; 6(Suppl. 1)S55–S60
- Crabos M., Wainer I. W., Cloix J. F. Measurement of endogenous Na,K-ATPase inhibitors in human plasma and urine using high-performance liquid chromatography. FEBS 1984; 176(1)223–228
- Tal D. M., Katchalsky S., Lichtstein D., Karlish S. J.D. Endogenous ouabain-like activity in bovine plasma. Biochem. Biophys. Res. Comm. 1986; 135(1)1–8